Cargando…
Absolute or Relative Quantification of Donor-derived Cell-free DNA in Kidney Transplant Recipients: Case Series
BACKGROUND. Donor-derived cell-free DNA (dd-cfDNA) is increasingly recognized as a valuable biomarker for acute transplant injury, with possible indications in the detection of cellular or humoral rejection and the guidance of immunosuppressive therapy. There is an ongoing debate on whether relative...
Autores principales: | Osmanodja, Bilgin, Akifova, Aylin, Budde, Klemens, Choi, Mira, Oellerich, Michael, Schütz, Ekkehard, Beck, Julia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547915/ https://www.ncbi.nlm.nih.gov/pubmed/34712778 http://dx.doi.org/10.1097/TXD.0000000000001237 |
Ejemplares similares
-
Donor-Derived Cell-Free DNA for Kidney Allograft Surveillance after Conversion to Belatacept: Prospective Pilot Study
por: Osmanodja, Bilgin, et al.
Publicado: (2023) -
Donor-Derived Cell-Free DNA in Biopsy-Proven Antibody-Mediated Rejection Versus Recurrent IgA Nephropathy After Kidney Transplantation
por: Akifova, Aylin, et al.
Publicado: (2023) -
Donor-derived Cell-free DNA in Infections in Kidney Transplant Recipients: Case Series
por: Goussous, Naeem, et al.
Publicado: (2020) -
Donor-derived cell-free DNA as a diagnostic tool in transplantation
por: Oellerich, Michael, et al.
Publicado: (2022) -
Causes of Renal Allograft Injury in Recipients With Normal Donor-derived Cell-free DNA
por: Xie, Wen Yan, et al.
Publicado: (2021)